Patent · US Active

Polymerases for nucleotide analogue incorporation

US11299720B2 · kind B2 · utility

0Cited by
21References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 14, 2020
Grant dateApr 12, 2022
Priority date
Expiry dateJul 14, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/52
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Compositions that include polymerases with features for improving entry of nucleotide analogues into active site regions and for coordinating with the nucleotide analogues in the active site region are provided. Methods of making the polymerases and of using the polymerases in sequencing and DNA replication and amplification as well as kinetic models of polymerase activity and computer-implemented methods of using the models are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.